HLS Therapeutics Inc. — Investor Relations & Filings
HLS Therapeutics Inc. is a specialty pharmaceutical company focused on the acquisition and commercialization of branded medicines across North America. The company targets products that address unmet needs, primarily in the treatment of psychiatric disorders and cardiovascular disease/risk reduction. Its commercial-stage portfolio includes CLOZARIL® (clozapine) for psychiatric disorders and VASCEPA® (icosapent ethyl) for cardiovascular risk reduction. HLS also commercializes NILEMDO® (bempedoic acid) and NEXLIZET® (bempedoic acid/ezetimibe combination) for the reduction of LDL-cholesterol in patients at risk of cardiovascular disease. HLS ensures reliable market access to these essential therapies by sourcing products directly from originators and best-in-class manufacturing partners.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2022-01-12 | English | |
| News release - English.pdf | 2021-12-20 | English | |
| News release - English.pdf | 2021-12-01 | English | |
| News release - English.pdf | 2021-11-11 | English | |
| Interim financial statements/report – English.pdf | 2021-11-04 | English | |
| News release - English.pdf | 2021-11-04 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
1 filing
| |||||
| 47537637 | News release - English.pdf | 2022-01-12 | English | ||
|
2021
14 filings
| |||||
| 23133609 | News release - English.pdf | 2021-12-20 | English | ||
| 47537641 | News release - English.pdf | 2021-12-01 | English | ||
| 47537646 | News release - English.pdf | 2021-11-11 | English | ||
| 13542712 | Interim financial statements/report – English.pdf | 2021-11-04 | English | ||
| 13542710 | News release - English.pdf | 2021-11-04 | English | ||
| 13542715 | 52-109F2 - Certification of interim filings - CEO (E).pdf | 2021-11-04 | English | ||
| 13542714 | 52-109F2 - Certification of interim filings - CFO (E).pdf | 2021-11-04 | English | ||
| 13542713 | Interim MD&A - English.pdf | 2021-11-04 | English | ||
| 22385803 | News release - English.pdf | 2021-10-21 | English | ||
| 47537655 | News release - English.pdf | 2021-10-04 | English | ||
| 13530917 | News release - English.pdf | 2021-08-16 | English | ||
| 47537660 | News release - English.pdf | 2021-08-05 | English | ||
| 47537677 | News release - English.pdf | 2021-08-04 | English | ||
| 21530924 | News release - English.pdf | 2021-07-22 | English | ||
Market data
Market data not available
Price history
Peer group · Wholesale of other household goods
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
111, Inc.
A tech-enabled healthcare platform connecting patients with…
|
YI | KY | Wholesale and retail trade |
|
AAYUSH ART AND BULLION LIMITED
Trades and distributes gold and silver bullion, coins, and …
|
540718 | IN | Wholesale and retail trade |
|
Al Hassan Ghazi Ibrahim Shaker Co.
Distributes air conditioning, home appliances, and energy m…
|
1214 | SA | Wholesale and retail trade |
|
ALLIANCE ENTERTAINMENT HOLDING CORP
Global wholesaler and distributor of home entertainment pro…
|
AENT | US | Wholesale and retail trade |
|
ALLIANCE PHARMA PLC
Specialty pharmaceutical company acquiring and marketing co…
|
APH | GB | Wholesale and retail trade |
|
ARATA CORPORATION
A wholesale trading company distributing daily consumer goo…
|
2733 | JP | Wholesale and retail trade |
|
Asker Healthcare Group AB
A partner to caregivers and patients providing medical prod…
|
ASKER | SE | Wholesale and retail trade |
|
Aspire & Innovative Advertising Limited
Distributes consumer durables and electronics via an asset-…
|
ASPIRE | IN | Wholesale and retail trade |
|
Ausupreme International Holdings Limited
Distributor of TGA-certified Australian health foods and We…
|
2031 | HK | Wholesale and retail trade |
|
Avidus Management Group Inc.
Marketer and distributor of nutraceutical products, supplem…
|
ASNHF | CA | Wholesale and retail trade |
HLS Therapeutics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/47563/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=47563 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=47563 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=47563 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 47563}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for HLS Therapeutics Inc. (id: 47563)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.